Greeks

What is CBDP?

  • Discovered in 2019, CBDP and THCP are rare cannabinoids produced in cannabis.
  • There is debate as to how CBDP contributes to the effects of cannabis.
  • The presence of CBDP may modulate the effects of other cannabinoids.
  • More research needs to be done to determine the safety and efficacy of THCP.

In late 2019, a team of Italian scientists discovered and isolated two new minor cannabinoids. Cannabidiphorol (CBDP) and tetrahydrocannabiphoral (THCP) are phytocannabinoids, compounds known to effectively mimic naturally-occurring chemicals in the human body. These two newcomers are among the one hundred and fifty cannabinoids discovered in the cannabis plant.

THC and CBD have been clinically researched for years to better understand their medicinal benefits. THC is famous for its intoxicating effects in addition to its pain, insomnia, and nausea relieving properties. CBD has gained a solid reputation for its anti-inflammatory, antispasmodic, antioxidant, and pain-relieving qualities.

CBDP does share some similarities in its molecular structure with CBD. However, CBD, like all the other naturally occurring cannabinoids contains only five links in its molecular design. CBDP’s elongated structure has seven links, and due to this unique chemical structure may be more medically beneficial than CBD. This is because this side chain can determine how strongly chemicals interact to the CB1 and 2 receptors.

CBDP essentially mimics both the biological activity and structure of CBD. Although extensive research is required, CBDP may prove to have even greater antioxidant, anti-inflammatory, and antispasmodic benefits than its cousin, CBD. Researchers are still attempting to understand exactly how CBDP binds with CB1 and CB2 receptors in the body’s endocannabinoid system.

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Research on CBDP

At present, there appears to be more interest in studying THCP than CBDP. This is mainly because the scientific community knows that CBD binds poorly with CB1 and CB2 receptors. Although CBDP does have a longer molecular chain, researchers are not expecting successful binding with the endocannabinoid receptors.

To put it succinctly, a member of the research team stated: “CBD has a poor binding affinity with both CB1 and CB2 receptors, so it’s possibly unlikely that a longer side chain will assist CBDP in binding more effectively with the body’s receptors.”

However, regular CBD has been used to great effect by many individuals for epilepsy symptom relief. In fact, there is now an FDA-approved drug called Epidiolex for the treatment of two rare forms of childhood epilepsy.

In the near future, clinical research may provide further proof of CBDP’s potential to treat a number of other neurological conditions in addition to epilepsy.

Applications for CBDP

This newly discovered cannabinoid may be further developed with applications specifically designed for anxiety and pain relief, functioning in a similar manner to CBD painkillers. Lower doses may be applicable with CBDP due to its longer molecular chain and concentrated nature.

Aside from obvious potential medical properties, CBDP has other uses. It may play a key role in understanding the entourage effect derived from specific cannabis strains. Furthermore, this minor cannabinoid may help point to exactly why the same cannabis strains will elicit such a broad range of effects on different people.

Cannbidiphorol is not exactly easy to find at this time, and not very many websites offer CBDP-infused products. The dearth of this cannabinoid on the market is probably because of its similarity to CBD. Anyone who has purchased CBD products knows they can be rather expensive. CBDP would inevitably be even pricier due to its rarity.

Cultivators are not producing cannbidiphorol-specific strains at present, although it is likely a matter of time before some start growing CBDP-rich plants. Once these strains are grown in abundance, CBDP will probably be extracted in the form of tinctures, concentrates, and isolates. CBDP products will be legal to procure in all fifty states, much like CBD.

Newer studies will undoubtedly unveil more minor cannabinoids and determine their functions and effects with greater specificity. CBD has proven to be a highly effective, non-invasive boon to the alternative medicine field.  CBDP probably isn’t far behind, and this minor cannabinoid may soon find itself batting in the major leagues!

MMJ Get Started

Sign Up for Medical Cannabis Today!

For potential patients, if you’re ready, we make it easy to connect with a medical marijuana doctor nearby or online. If you are interested in getting certified, please fill out the MMJ patient registration form below and press submit to get started. See if you qualify today!

HTTPS Secure

MedCard Registration Form

We respect your privacy
Scroll to Top